What happens if a patient discontinues the study or withdraws consent?
Patients who discontinue the study treatment for reasons other than documented disease progression will continue to have tumor assessments performed every six weeks until documented disease progression or the start of a new chemotherapy. Patients who withdraw consent and do not wish to have radiological assessments will be followed for survival every six weeks.
